Rivara Matthew B, Mehrotra Rajnish
Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, WA.
Kidney Research Institute and Harborview Medical Center, University of Washington, Seattle, WA.
Semin Nephrol. 2017 Mar;37(2):181-193. doi: 10.1016/j.semnephrol.2016.12.008.
The optimal timing of initiation of maintenance dialysis in patients with end-stage renal disease currently is unknown. This transition period is one of exceptionally high vulnerability for patients; annual mortality rates in stage 5 chronic kidney disease through the first year of maintenance dialysis exceed 20%. The results of the Initiating Dialysis Early and Late (IDEAL) study, a randomized trial that tested the impact of dialysis initiation at two different levels of kidney function on outcomes, showed no significant difference in survival or other patient-centered outcomes between treatment groups. These data have challenged the established paradigm of using estimates of glomerular filtration as the primary guide for initiation of maintenance dialysis and illustrate the compelling need for research to optimize the high-risk transition period from chronic kidney disease to end-stage renal disease. This article reviews the findings of the IDEAL study and summarizes the evolution of research findings, updated clinical practice guidelines, and trends in dialysis initiation practices in the United States in the 6 years since the publication of the results from IDEAL. Complementary strategies to the use of estimated glomerular filtration rate to optimally time the initiation of maintenance dialysis and potentially improve patient-centered outcomes also are considered.
目前,终末期肾病患者开始维持性透析的最佳时机尚不清楚。这个过渡阶段对患者来说是一个特别脆弱的时期;在5期慢性肾病患者中,维持性透析第一年的年死亡率超过20%。“早期和晚期开始透析(IDEAL)”研究是一项随机试验,测试了在两个不同肾功能水平开始透析对预后的影响,结果显示治疗组之间在生存率或其他以患者为中心的预后方面没有显著差异。这些数据对以肾小球滤过率估计值作为开始维持性透析的主要指导这一既定模式提出了挑战,并表明迫切需要开展研究,以优化从慢性肾病到终末期肾病的高风险过渡期。本文回顾了IDEAL研究的结果,并总结了自IDEAL研究结果发表以来6年里美国研究结果的演变、更新的临床实践指南以及透析开始实践的趋势。还考虑了使用估计肾小球滤过率之外的补充策略,以最佳时机开始维持性透析,并有可能改善以患者为中心的预后。